This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: The Innovations of David Budd
Introduction
David Budd is an accomplished inventor based in Wayne, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address inflammatory diseases. His work is characterized by a commitment to advancing medical science and improving patient outcomes.
Latest Patents
David Budd holds a patent for LPAR—substituted cyanopyrazole compounds. This patent includes compounds of the formula (I), along with pharmaceutically acceptable salts. The compounds are designed to be effective in treating inflammatory diseases and disorders, such as pulmonary fibrosis. His innovative approach in this area showcases his dedication to addressing critical health issues.
Career Highlights
Throughout his career, David has been associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His role at the company has allowed him to work on groundbreaking research and development projects that have the potential to change lives.
Collaborations
David has collaborated with notable colleagues, including Yimin Qian and Ryan Craig Schoenfeld. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
David Budd's contributions to the field of pharmaceuticals through his patent and work at Hoffmann-La Roche Inc. highlight his role as a significant inventor. His dedication to developing treatments for inflammatory diseases underscores the importance of innovation in healthcare.